The IMS Institute for Healthcare Informatics worked up a methodology for assessing the effectiveness of pharma’s social media efforts across Facebook, Twitter and YouTube.
The IMS Institute for Healthcare Informatics worked up a methodology for assessing the effectiveness of pharma’s social media efforts across Facebook, Twitter and YouTube, according to three indices: reach (total number of people reached through each channel via likes, shares and re-tweets); relevance (extent to which content is being shared and forwarded); and relationship (amount of back and forth between company and patient).
Those pharmas hitting the trifecta scored best on the cumulative “Social Media Engagement Index.” Results were tallied over a two-year period. Here are the top ten pharma engagers, per IMS Health. To read the full report, which discusses the role of Wikipedia, healthcare professionals’ use of social media, and a summary of social media regulatory policy in the US, Canada and the EU,
IMS Health Social Engagement Index
1. Johnson & Johnson
2. GlaxoSmithKline
3.Novo Nordisk
4. Pfizer
5. Novartis
6. Boehringer Ingelheim
7. Bayer
8. Merck
9. AstraZeneca
10. UCB
In a separate article, consultants at Capgemini Consulting Life Sciences wonder if social media in pharma has
